Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Jeffrey A. Meckler | CEO and Director | 2024-11-25 | 42,553 | $1.18 | $50.00kBuy |
Jeffrey A. Meckler | CEO and Director | 2024-08-08 | 84,932 | $1.83 | $155.00kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Dexcel Pharma Technologies Ltd | 739.51% | 4,234,897 | $46.97M | Insider |
Michael James Newman | 238.95% | 1,368,356 | $15.18M | Insider |
Glen R. Anderson | 227.77% | 1,304,318 | $14.46M | Insider |
Vanguard Group Inc | 44.75% | 256,265 | $2.84M | Institution |
Jeffrey A. Meckler | 35.42% | 202,859 | $2.25M | Insider |
John W. Kozarich | 26.50% | 151,761 | $1.68M | Insider |
Investment House LLC | 22.50% | 128,851 | $1.43M | Institution |
Geode Capital Management LLC | 21.82% | 124,967 | $1.39M | Institution |
Anthony J. Maddaluna | 9.35% | 53,570 | $594.09k | Insider |
Strategy Asset Managers LLC | 7.92% | 45,336 | $502.78k | Institution |